References
- Cochat P, Rumsby G. Primary hyperoxaluria. N Engl J Med 2013;369:649-58. https://doi.org/10.1056/NEJMra1301564
- Purdue PE, Takada Y, Danpure CJ. Identification of mutations associated with peroxisome-to-mitochondrion mistargeting of alanine/glyoxylate aminotransferase in primary hyperoxaluria type 1. J Cell Biol 1990;111(6 Pt 1):2341-51. https://doi.org/10.1083/jcb.111.6.2341
- Cramer SD, Ferree PM, Lin K, Milliner DS, Holmes RP. The gene encoding hydroxypyruvate reductase (GRHPR) is mutated in patients with primary hyperoxaluria type II. Hum Mol Genet 1999;8:2063-9. https://doi.org/10.1093/hmg/8.11.2063
- Belostotsky R, Seboun E, Idelson GH, Milliner DS, Becker-Cohen R, Rinat C, et al. Mutations in DHDPSL are responsible for primary hyperoxaluria type III. Am J Hum Genet 2010;87:392-9. https://doi.org/10.1016/j.ajhg.2010.07.023
- Hoppe B. An update on primary hyperoxaluria. Nat Rev Nephrol 2012;8:467-75. https://doi.org/10.1038/nrneph.2012.113
- Kim HH, Koh HI, Ku BI, Lee HS. Late-onset primary hyperoxaluria diagnosed after renal transplantation presented with early recurrence of disease. Nephrol Dial Transplant 2005;20:1738-40. https://doi.org/10.1093/ndt/gfh889
- Kim SE, Kim SJ, Chu ST, Yang SH, Kim YS, Cha RH. A rare case of hyperoxaluria presenting with acute liver injury and stone-free kidney injury. Kidney Res Clin Pract 2015;34:113-6. https://doi.org/10.1016/j.krcp.2014.09.006
- Cochat P, Deloraine A, Rotily M, Olive F, Liponski I, Deries N. Epidemiology of primary hyperoxaluria type 1. Nephrol Dial Transplant 1995;10 Suppl 8:3-7.
- van Woerden CS, Groothoff JW, Wanders RJ, Davin JC, Wijburg FA. Primary hyperoxaluria type 1 in the Netherlands: prevalence and outcome. Nephrol Dial Transplant 2003;18:273-9. https://doi.org/10.1093/ndt/18.2.273
- Harambat J, van Stralen KJ, Espinosa L, Groothoff JW, Hulton SA, Cerkauskiene R, et al. Characteristics and outcomes of children with primary oxalosis requiring renal replacement therapy. Clin J Am Soc Nephrol 2012;7:458-65. https://doi.org/10.2215/CJN.07430711
- North American Pediatric Renal Trials and Collaborative Studies. NAPRTCS 2011 Annual Dialysis Report. https://web.emmes.com/study/ped/annlrept/annualrept2011.pdf.
- Hattori S, Yosioka K, Honda M, Ito H. Japanese Society for Pediatric Nephrology. The 1998 report of the Japanese national registry data on pediatric end-stage renal disease patients. Pediatr Nephrol 2002;17:456-61. https://doi.org/10.1007/s00467-002-0848-8
- Al-Eisa AA, Samhan M, Naseef M. End-stage renal disease in Kuwaiti children: an 8-year experience. Transplant Proc 2004;36:1788-91. https://doi.org/10.1016/j.transproceed.2004.07.024
- Kamoun A, Lakhoua R. End-stage renal disease of the Tunisian child: epidemiology, etiologies, and outcome. Pediatr Nephrol 1996;10:479-82. https://doi.org/10.1007/s004670050143
- Williams EL, Acquaviva C, Amoroso A, Chevalier F, Coulter-Mackie M, Monico CG, et al. Primary hyperoxaluria type 1: update and additional mutation analysis of the AGXT gene. Hum Mutat 2009;30:910-7. https://doi.org/10.1002/humu.21021
- Hopp K, Cogal AG, Bergstralh EJ, Seide BM, Olson JB, Meek AM, et al. Rare Kidney Stone Consortium. Phenotype-genotype correlations and estimated carrier frequencies of primary hyperoxaluria. J Am Soc Nephrol 2015;26:2559-70. https://doi.org/10.1681/ASN.2014070698
- Monico CG, Rossetti S, Olson JB, Milliner DS. Pyridoxine effect in type I primary hyperoxaluria is associated with the most common mutant allele. Kidney Int 2005;67:1704-9. https://doi.org/10.1111/j.1523-1755.2005.00267.x
- Harambat J, Fargue S, Acquaviva C, Gagnadoux MF, Janssen F, Liutkus A, et al. Genotype-phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome. Kidney Int 2010;77:443-9. https://doi.org/10.1038/ki.2009.435
- van Woerden CS, Groothoff JW, Wijburg FA, Annink C, Wanders RJ, Waterham HR. OxalEurope Consortium. Clinical implications of mutation analysis in primary hyperoxaluria type 1. Kidney Int 2004;66:746-52. https://doi.org/10.1111/j.1523-1755.2004.00796.x
- Mandrile G, van Woerden CS, Berchialla P, Beck BB, Acquaviva Bourdain C, Hulton SA, et al. Data from a large European study indicate that the outcome of primary hyperoxaluria type 1 correlates with the AGXT mutation type. Kidney Int 2014;86:1197-204. https://doi.org/10.1038/ki.2014.222
- Rumsby G, Williams E, Coulter-Mackie M. Evaluation of mutation screening as a first line test for the diagnosis of the primary hyperoxalurias. Kidney Int 2004;66:959-63. https://doi.org/10.1111/j.1523-1755.2004.00842.x
- Frishberg Y, Rinat C, Shalata A, Khatib I, Feinstein S, Becker-Cohen R, et al. Intra-familial clinical heterogeneity: absence of genotype-phenotype correlation in primary hyperoxaluria type 1 in Israel. Am J Nephrol 2005;25:269-75. https://doi.org/10.1159/000086357
- Milliner DS, Eickholt JT, Bergstralh EJ, Wilson DM, Smith LH. Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria. N Engl J Med 1994;331:1553-8. https://doi.org/10.1056/NEJM199412083312304
- Hoppe B, Kemper MJ, Bokenkamp A, Portale AA, Cohn RA, Langman CB. Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end-stage renal failure. Kidney Int 1999;56:268-74. https://doi.org/10.1046/j.1523-1755.1999.00546.x
- Illies F, Bonzel KE, Wingen AM, Latta K, Hoyer PF. Clearance and removal of oxalate in children on intensified dialysis for primary hyperoxaluria type 1. Kidney Int 2006;70:1642-8. https://doi.org/10.1038/sj.ki.5001806
- Kemper MJ, Nolkemper D, Rogiers X, Timmermann K, Sturm E, Malago M, et al. Preemptive liver transplantation in primary hyperoxaluria type 1: timing and preliminary results. J Nephrol 1998;11 Suppl 1:46-8.
- Cochat P, Groothoff J. Primary hyperoxaluria type 1: practical and ethical issues. Pediatr Nephrol 2013;28:2273-81. https://doi.org/10.1007/s00467-013-2444-5
- Malla I, Lysy PA, Godefroid N, Smets F, Malaise J, Reding R, et al. Two-step transplantation for primary hyperoxaluria: cadaveric liver followed by living donor related kidney transplantation. Pediatr Transplant 2009;13:782-4. https://doi.org/10.1111/j.1399-3046.2008.01049.x
- Mor E, Nesher E, Ben-Ari Z, Weissman I, Shaharabani E, Eizner S, et al. Sequential liver and kidney transplantation from a single living donor in two young adults with primary hyperoxaluria type 1. Liver Transpl 2013;19:646-8. https://doi.org/10.1002/lt.23642
- Allard L, Cochat P, Leclerc AL, Cachat F, Fichtner C, De Souza VC, et al. Renal function can be impaired in children with primary hyperoxaluria type 3. Pediatr Nephrol 2015;30:1807-13. https://doi.org/10.1007/s00467-015-3090-x